Efficacy and Safety of Rilzabrutinib - A Novel Oral Treatment in Asthma: Results From a Double Blind Placebo Controlled Phase 2 Study
D21. TERMINATOR: CONTROL OF AIRWAY INFLAMMATION AND IMMUNE RESPONSE IN ASTHMA（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要